Form 4 holding
Chief Medical Officer
Fulcrum Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 400,000
- Estimated value
- Report date
- 18 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount